370 The Epi-RTMtechnology produces a polyclonal TIL product (LYL845) with a greater expansion success rate across hot and cold tumors, improved product phenotype, and maintenance of TCR diversity
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.